Treatment of selective mutism: Focus on selective serotonin reuptake inhibitors

Pharmacotherapy

Volumn 28, Issue 2, 2008, Pages 214-224

  Kaakeh, Yaman ^a   Stumpf, Janice L ^b  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Anxiety; Fluoxetine; Selective mutism; Selective serotonin reuptake inhibitors; SSRIs

Indexed keywords

FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; PAROXETINE; PHENELZINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY; CHILD; CHILD BEHAVIOR; CHILD PSYCHIATRY; CLINICAL TRIAL; CONSTIPATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; HUMAN; HYPOTENSION; INSOMNIA; MUTISM; PARENT; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; SOCIAL BEHAVIOR; SOCIAL SUPPORT; TEACHER; TREATMENT DURATION; URINE RETENTION; WEIGHT GAIN;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; MUTISM; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS;

EID: 38849129463     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.2.214     Document Type: Review

References (49)

1. American Psychiatric Association. Diagnostic and Statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.
2. Krysanski VL. A brief review of selective mutism literature. J Psychol 2003;137:29-40.
3. Dow SP, Sonies BC, Scheib D, Moss SE, Leonard HL. Practical guidelines for the assessment and treatment of selective mutism. J Am Acad Child Adolesc Psychiatry 1995;34:836-46.
4. Sharp WG, Sherman C, Gross AM. Selective mutism and anxiety: a review of the current conceptualization of the disorder. J Anx Dis 2007;21:568-79.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
6. Cohan SL, Price JM, Stein MB. Suffering in silence: why a developmental psychopathology perspective on selective mutism is needed. J Dev Behav Pediatr 2006;27:341-55.
7. Black B, Uhde TW. Psychiatric characteristics of children with selective mutism: a pilot study. J Am Acad Child Adolesc Psychiatry 1995;34:847-56.
8. Kumpulainen K. Phenomenology and treatment of selective mutism. CNS Drugs 2002;16:175-80.
9. Kristensen H. Selective mutism and comorbidity with developmental disorder/delay anxiety disorder, and elimination disorder. J Am Acad Child Adolesc Psychiatry 2000;39:249-56.
10. Steinhausen HC, Juzi C. Elective mutism: an analysis of 100 cases. J Am Acad Child Adolesc Psychiatry 1996;35:606-14.
11. Krohn DD, Weckstein SM, Wright HL. A study of the effectiveness of a specific treatment for elective mutism. J Am Acad Child Adolesc Psychiatry 1992;31:711-18.
12. Dummit ES, Klein RG, Tancer NK, Asche B, Martin J, Fairbanks JA. Systematic assessment of 50 children with selective mutism. J Am Acad Child Adolesc Psychiatry 1997;36:653-60.
13. Steinhausen HC, Adamek R. The family history of children with elective mutism: a research report. Eur Child Adolesc Psychiatry 1997;6:107-11.
14. Kolvin I, Fundudis T. Elective mute children: psychological development and background factors. J Child Psychol Psychiatry 1981;22:219-32.
15. Simons D, Goode S, Fombonne E. Elective mutism and chromosome 18 abnormality Eur Child Adolesc Psychiatry 1997;6:112-14.
16. Grosso S, Cioni M, Pucci L, Morgese G, Balestri P. Selective mutism, speech delay, dysmorphisms, and deletion of the short arm of chromosome 18: a distinct entity [letter]? J Neurol Neurosurg Psychiatry 1999;67:830-1.
17. Yeganeh R, Beidel DC, Turner SM, Pina AA, Silverman WK. Clinical distinctions between selective mutism and social phobia: an investigation of childhood psychopathology. J Am Acad Child Adolesc Psychiatry 2003;42:1069-75.
18. Kopp S, Gillberg C. Selective mutism: a population-based study: a research note. J Child Psychol Psychiatry 1997;38:257-62.
19. Kumpulainen K, Räsänen E, Raaska H, Somppi V. Selective mutism among second-graders in elementary school. Eur Child Adolesc Psychiatry 1998;7:24-9.
20. Bergman RL, Piacentini J, McCracken JT. Prevalence and description of selective mutism in a school-based sample. J Am Acad Child Adolesc Psychiatry 2002;41:938-46.
21. Gordon N. Mutism: elective or selective, and acquired. Brain Dev 2001;23:83-7.
22. Schwartz RH, Shipon-Blum E. "Shy" child? Don't overlook selective mutism. Contemp Pediatr 2005;22(7):30-9.
23. Remschmidt H, Poller M, Herpertz-Dahlmann B, Hennighausen K, Gutenbrunner C. A follow-up study of 45 patients with elective mutism. Eur Arch Psychiatry Clin Neurosci 2001;251:284-96.
24. Steinhausen HC, Wachter M, Laimböck K, Metzke CW. A long-term outcome study of selective mutism in childhood. J Child Psychol Psychiatr 2006;47:751-6.
25. Kristensen H. Multiple informants' report of emotional and behavioural problems in a nation-wide sample of selective mute children and controls. Eur Child Adolesc Psychiatry 2001;10:135-42.
26. Rye MS, Ullman D. The successful treatment of long-term selective mutism: a case study. J Behav Ther Exp Psychiatry 1999;30:313-23.
27. Cohan SL, Chavira DA, Stein MB. Practitioner review: psychosocial interventions for children with selective mutism: a critical evaluation of the literature from 1990-2005. J Child Psychol Psychiatr 2006;47:1085-97.
28. Stein MT, Rapin I, Yapko D. Selective mutism. J Dev Behav Pediatr 2001;22(2 suppl):S123-6.
29. Carlson JS, Kratochwill TR, Johnston H. Prevalence and treatment of selective mutism in clinical practice: a survey of child and adolescent psychiatrists. J Child Adolesc Psychopharmacol 1994;4:281-91.
30. Golwyn DH, Weinstock RC. Phenelzine treatment for elective mutism: a case report. J Clin Psychiatry 1990;51:384-5.
31. Golwyn DH, Sevlie CP. Phenelzine treatment of selective mutism in four prepubertal children. J Child Adolesc Psychopharmacol 1999;9:109-13.
32. Black B, Uhde TW. Elective mutism as a variant of social phobia. J Am Acad Child Adolesc Psychiatry 1992;31:1090-4.
33. Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994;33:1000-6.
34. Dummit ES, Klein RG, Tancer NK, Asche B, Martin J. Fluoxetine treatment of children with selective mutism: an open trial. J Am Acad Child Adolesc Psychiatry 1996;35:615-21.
35. Wright HH, Cuccaro ML, Leonhardt TV, Kendall DF, Anderson JH. Case study: fluoxetine in the multimodal treatment of a preschool child with selective mutism. J Am Acad Child Adolesc Psychiatry 1995;34:857-62.
36. Motavalli N. Fluoxetine for (s)elective mutism [letter]. J Am Acad Child Adolesc Psychiatry 1995;34:701-2.
37. Guna-Dumitrescu L, Pelletier G. Successful multimodal treatment of a child with selective mutism: a case report [letter]. Can J Psychiatry 1996;41:417.
38. Berger I, Jaworowski S, Gross-Tsur V. Selective mutism: a review of the concept and treatment. Isr Med Assoc J 2002;4(12):1135-7.
39. Boon F. The selective mutism controversy (continued) [letter]. J Am Acad Child Adolesc Psychiatry 1994;33:283.
40. Lafferty JE, Constantino JN. Fluvoxamine in selective mutism. J Am Acad Child Adolesc Psychiatry 1998;37:12-13.
41. Carlson JS, Kratochwill TR, Johnston HF. Sertraline treatment of 5 children diagnosed with selective mutism: a single-case research trial. J Child Adolesc Psychopharmacol 1999;9:293-306.
42. Lehman RB. Rapid resolution of social anxiety disorder, selective mutism, and separation anxiety with paroxetine in an 8-year-old girl [letter]. J Psychiatry Neurosci 2002;27:124-5.
43. Rupp SN. Haloperidol for Tourette's disorder plus selective mutism [letter]. J Am Acad Child Adolesc Psychiatry 1999;38:7.
44. Murphy TK, Bengtson MA, Tan JY, Carbonell E, Levin GM. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review, lnt Clin Psychopharmacol 2000;15(suppl 2):S47-63.
45. Schwartz RH, Freedy AS, Sheridan MJ. Selective mutism: are primary care physicians missing the silence? Clin Pediatr 2006;45:43-8.
46. Black B, Uhde TW, Tancer ME. Fluoxetine for the treatment of social phobia [letter]. J Clin Psychopharmacol 1992;12:293-5.
47. Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001;344:1279-85.
48. U.S. Food and Drug Administration. Public health advisory: suicidality in children and adolescents being treated with antidepressant medications, October 15, 2004. Available from http://www.fda.gov/cder/drug/ antidepressants/SSRIPHA20041.htm. Accessed May 15, 2007.
49. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment. JAMA 2007;297:1683-96.